Not Medicare Enrolled

Dr. Adriana Carrillo Iregui, MD

Pediatric Endocrinology · Miami, FL
Low-engagement
3100 SW 62ND AVE STE 102, Miami, FL 33155
3056628368
In practice since 2006 (19 years)
NPI: 1518994524 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Carrillo Iregui from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Carrillo Iregui? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Carrillo Iregui

Dr. Adriana Carrillo Iregui is a pediatric endocrinology in Miami, FL, with 19 years in practice.

Between the years covered by Open Payments, Dr. Carrillo Iregui received a total of $10,529 from 45 pharmaceutical and/or device companies across 249 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pediatric endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Carrillo Iregui is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice$ $10,529 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$10,529
Total received (2018-2024)
Avg $1,504/year across 7 years
Top 23% in FL for pediatric endocrinology
45
Companies
249
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,145 (77.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,384 (22.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,182
2023
$1,469
2022
$1,423
2021
$516
2020
$418
2019
$1,679
2018
$842

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
SANOFI-AVENTIS U.S. LLC
$2,497
Janssen Research & Development, LLC
$1,238
Novo Nordisk Inc
$978
Insulet Corporation
$779
Tandem Diabetes Care, Inc.
$656
BETA BIONICS, INC.
$504
Ascendis Pharma Inc
$288
Xeris Pharmaceuticals, Inc.
$279
Dexcom, Inc.
$249
Ascendis Pharma, Inc.
$249
Alexion Pharmaceuticals, Inc.
$234
Abbott Laboratories
$205
Neurocrine Biosciences, Inc.
$176
PFIZER INC.
$167
Lilly USA, LLC
$160
ABBVIE INC.
$154
AbbVie, Inc.
$153
Ultragenyx Pharmaceutical Inc.
$125
Rhythm Pharmaceuticals, Inc.
$120
LifeScan, Inc.
$119
Eton Pharmaceuticals, Inc.
$102
Amneal Pharmaceuticals LLC
$100
AbbVie Inc.
$91
TOLMAR Pharmaceuticals, Inc.
$88
Zealand Pharma US, Inc.
$82
Ipsen Biopharmaceuticals, Inc
$77
Kyowa Kirin, Inc.
$71
BioMarin Pharmaceutical Inc.
$69
Becton, Dickinson and Company
$54
Endo Pharmaceuticals Inc.
$52
LIFESCAN, INC.
$40
Amryt Pharma Holdings Ltd
$39
Gemini Laboratories, LLC
$36
Arbor Pharmaceuticals, Inc.
$35
Azurity Pharmaceuticals, Inc.
$35
IBSA Pharma Inc.
$33
Medtronic, Inc.
$30
Embecta Corp.
$24
Sandoz Inc.
$24
Tolmar, Inc.
$23
Companion Medical, Inc.
$21
Endo USA, Inc.
$20
Chiesi USA, Inc.
$18
GENZYME CORPORATION
$18
ARBOR PHARMACEUTICALS, INC.
$16
Top 3 companies account for 44.8% of total payments
Associated products mentioned in payments ›
ALKINDI · AMPLATZER PICCOLO · BAQSIMI · BD Nano · BD Nano 2nd Gen Pen Needle · Crysvita · Dexcom CGM · Dexcom G6 Transmitter · FENSOLVI · FIASP · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GENOTROPIN · GVOKE HYPOPEN · GVOKE PFS · HUMALOG · IMCIVREE · INCRELEX · InPen · Increlex · LICART · LUPRON DEPOT · Lupron Depot · MINIMED 770G · MPS I-DISEASE · MYALEPT · Macrilen · Norditropin · OMNITROPE · OT Verio Flex Starter Kit · Omnipod · OneTouch · SKYTROFA · STRENSIQ · SUPPRELIN · SUPPRELIN LA · Saxenda · Skytrofa · Sogroya · Somatuline Depot · Strensiq · Synthroid · TZIELD · Tirosint · Tresiba · Triptodur · UNITHROID · VOXZOGO · Victoza · ZEGALOGUE · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (77%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a pediatric endocrinology in Miami?
Compare pediatric endocrinologys in the Miami area by procedure volume, costs, and industry payment transparency.
Browse pediatric endocrinologys nearby

Geographic Context

Pediatric Endocrinologys within 10 mi
28
Per 100K population
1.0
County median income
$68,694
Nearest hospital
KERALTY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment— Not enrolledN/A
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Carrillo Iregui is a pediatric endocrinology, and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Carrillo Iregui receive payments from pharmaceutical companies?
Yes. Dr. Carrillo Iregui received a total of $10,529 from 45 companies across 249 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Carrillo Iregui) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →